This study provides the first evidence that high‐dose sinomenine's (SIN) attenuates hepatic I/R‐induced inflammation and oxidative stress in diabetes mellitus (DM) rats, potentially through activation of the Nrf‐2/HO‐1 signaling pathway. This evidence concerns the gene HMOX1 and diabetes mellitus.